Derek Bell v. Pfizer, Inc.

District Court, E.D. Pennsylvania·Decided August 13, 2026·No. 2:26-cv-02979·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

DEREK BELL, : Plaintiff, : : v. : CIVIL ACTION NO. 26-CV-2979 : PFIZER, INC., : Defendant. :

MEMORANDUM

PADOVA, J. AUGUST 13 , 2026

On May 1, 2026, Derek Bell submitted a pro se Complaint against Pfizer, Inc. (Pfizer) and filed a Motion to Proceed In Forma Pauperis. (ECF Nos. 1 & 2.) After his Motion to Proceed In Forma Pauperis was denied for lack of sufficient information (ECF No. 5), Bell submitted new applications for leave to proceed in forma pauperis. (See ECF Nos. 6, 8.) He also filed an Amended Complaint against Pfizer alleging negligence, strict products liability, failure to warn, and negligent marketing and promotion. (ECF No. 7.) For the following reasons, the Court will grant Bell leave to proceed in forma pauperis and dismiss the Complaint for lack of subject matter jurisdiction. I. FACTUAL ALLEGATIONS1 Bell states that he is a citizen of Pennsylvania. (Am. Compl. at 4.) He alleges that the Pfizer corporation is “organized under the laws of a different state with its principal place of business outside Pennsylvania.” (Id.) According to Bell, Pfizer manufactured, marketed, and

1 The factual allegations set forth in this Memorandum are taken from Bell’s Amended Complaint (Am. Compl.). (See ECF No. 7.) The Court adopts the sequential pagination supplied by the CM/ECF docketing system. distributed Avinza, an extended-release morphine sulfate, which was prescribed to Bell after a snowboard injury when he was a minor. (Id. at 4, 12.) Bell took Avinza as prescribed and developed psychological dependence on it, which progressed into chronic opioid addiction. (Id. at 6.) After two decades of addiction, Bell allegedly suffered multiple overdoses, including life-

threatening events, hospitalizations, coma, and repeated inpatient treatment admissions. (Id.) He lost educational, career, and monetary opportunities, was incarcerated, and suffered severe emotional and psychological distress. (Id. at 6, 10.) Bell contends that Pfizer promoted Avinza through financial incentive mechanisms aimed at reducing resistance to prescribing the medication and to increase consumption. (Id. at 5.) Pfizer allegedly utilized manufacturer’s discount coupons, subsidized prescription programs, and cost-reduction tools linked to continued use. (Id.) The use of the incentives allegedly constituted “direct-to-consumer influence” and were purportedly designed to affect patient behavior and demand, “not merely physician decision-making.” (Id. at 7.) Bell further claims the marketing practices “compromised independent medical judgment.” (Id.) Bell asserts that

the financial incentives “materially increased the likelihood that Avinza would be prescribed, particularly in borderline or non-critical cases.” (Id. at 5.) In his Complaint, Bell asserts that Pfizer did not adequately warn of the severity and likelihood of addiction, especially in minors, whom Pfizer knew or should have known are particularly vulnerable to addiction. (Id. at 7-8.) He alleges that any warnings provided were not sufficient to counterbalance the incentive-driven messaging. (Id. at 7.) Bell admits that the claims arose outside of the applicable statute of limitations, but argues tolling doctrines and the discovery rule apply because he was allegedly incapacitated by addiction for two decades, and he “only recently” attained the ability to understand and assert his legal rights. (Id. at 8.) Bell asserts four state law claims and seeks money damages. (Id. at 8-10.) II. STANDARD OF REVIEW The Court will grant Bell leave to proceed in forma pauperis because he appears unable

to pay the filing fee in this matter. Pursuant to that statute, the Court must screen the Complaint dismiss it if, among other grounds, it fails to state a claim. See 28 U.S.C. § 1915(e)(2)(B)(ii). Whether a complaint fails to state a claim under § 1915(e)(2)(B)(ii) is governed by the same standard applicable to motions to dismiss under Federal Rule of Civil Procedure 12(b)(6), see Tourscher v. McCullough, 184 F.3d 236, 240 (3d Cir. 1999), which requires the Court to determine whether the complaint contains “sufficient factual matter, accepted as true, to state a claim to relief that is plausible on its face,” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quotations omitted); Talley v. Wetzel, 15 F.4th 275, 286 n.7 (3d Cir. 2021). At this early stage of the litigation, the Court will accept the facts alleged in the pro se complaint as true, draw all reasonable inferences in the plaintiff’s favor, and ask only whether the complaint contains facts

sufficient to state a plausible claim. See Shorter v. United States, 12 F.4th 366, 374 (3d Cir. 2021), abrogation on other grounds recognized by Fisher v. Hollingsworth, 115 F.4th 197 (3d Cir. 2024). Conclusory allegations do not suffice. Iqbal, 556 U.S. at 678. As Bell is proceeding pro se, the Court construes his allegations liberally. Vogt v. Wetzel, 8 F.4th 182, 185 (3d Cir. 2021) (citing Mala v. Crown Bay Marina, Inc., 704 F.3d 239, 244-45 (3d Cir. 2013)). In addition, the Court must dismiss the action “[i]f the court determines at any time that it lacks subject-matter jurisdiction.” Fed. R. Civ. P. 12(h)(3); Grp. Against Smog & Pollution, Inc. v. Shenango Inc., 810 F.3d 116, 122 n.6 (3d Cir. 2016) (explaining that “an objection to subject matter jurisdiction may be raised at any time [and] a court may raise jurisdictional issues sua sponte”). A plaintiff commencing an action in federal court bears the burden of establishing federal jurisdiction. See Lincoln Benefit Life Co. v. AEI Life, LLC, 800 F.3d 99, 105 (3d Cir. 2015) (“The burden of establishing federal jurisdiction rests with the party asserting its existence.” (citing DaimlerChrysler Corp. v. Cuno, 547 U.S. 332, 342 n.3 (2006))).

Free access — add to your briefcase to read the full text and ask questions with AI

Derek Bell v. Pfizer, Inc., (E.D. Pa. 2026).

Derek Bell v. Pfizer, Inc. (Derek Bell v. Pfizer, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

DaimlerChrysler Corp. v. Cuno
547 U.S. 332 (Supreme Court, 2006)
Arbaugh v. Y & H Corp.
546 U.S. 500 (Supreme Court, 2006)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
David Rockefeller v. Comcast Corp
424 F. App'x 82 (Third Circuit, 2011)
Washington v. HOVENSA LLC
652 F.3d 340 (Third Circuit, 2011)
Kelley Mala v. Crown Bay Marina
704 F.3d 239 (Third Circuit, 2013)
Zambelli Fireworks Manufacturing Co. v. Wood
592 F.3d 412 (Third Circuit, 2010)
Lincoln Property Co. v. Roche
546 U.S. 81 (Supreme Court, 2005)
Lincoln Benefit Life Co. v. AEI Life, LLC
800 F.3d 99 (Third Circuit, 2015)
S Freedman Co Inc v. Raab
180 F. App'x 316 (Third Circuit, 2006)
William Craven v. Amanda Leach
647 F. App'x 72 (Third Circuit, 2016)
Steven Vogt v. John Wetzel
8 F.4th 182 (Third Circuit, 2021)
Christopher Shorter v. United States
12 F.4th 366 (Third Circuit, 2021)
Quintez Talley v. John E. Wetzel
15 F.4th 275 (Third Circuit, 2021)
McCracken v. ConocoPhillips Co.
335 F. App'x 161 (Third Circuit, 2009)